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Transient receptor potential ankyrin 1 (TRPA1) non-selective ligand-gated cation chan-
nels are mostly expressed in primary sensory neurons. Polysulfides (POLYs) are Janus- 
faced substances interacting with numerous target proteins and associated with 
both protective and detrimental processes. Activation of TRPA1 in sensory neurons, 
consequent somatostatin (SOM) liberation and action on sst4 receptors have recently 
emerged as mediators of the antinociceptive effect of organic trisulfide dimethyl trisulfide 
(DMTS). In the frame of the present study, we set out to compare the participation of this 
mechanism in antinociceptive and anti-inflammatory effects of inorganic sodium POLY 
and DMTS in carrageenan-evoked hind-paw inflammation. Inflammation of murine hind 
paws was induced by intraplantar injection of carrageenan (3% in 30 µL saline). Animals 
were treated intraperitoneally with POLY (17 µmol/kg) or DMTS (250 µmol/kg) or their 
respective vehicles 30 min prior paw challenge and six times afterward every 60 min. 
Mechanical pain threshold and swelling of the paws were measured by dynamic plantar 
aesthesiometry and plethysmometry at 2, 4, and 6  h after initiation of inflammation. 
Myeloperoxidase (MPO) activity in the hind paws were detected 6 h after challenge by 
luminescent imaging. Mice genetically lacking TRPA1 ion channels, sst4 receptors and 
their wild-type counterparts were used to examine the participation of these proteins in 
POLY and DMTS effects. POLY counteracted carrageenan-evoked mechanical hyper-
algesia in a TRPA1 and sst4 receptor-dependent manner. POLY did not influence paw 
swelling and MPO activity. DMTS ameliorated all examined inflammatory parameters. 
Mitigation of mechanical hyperalgesia and paw swelling by DMTS were mediated 
through sst4 receptors. These effects were present in TRPA1 knockout animals, too. 
DMTS inhibited MPO activity with no participation of the sensory neuron–SOM axis. 
While antinociceptive effects of POLY are transmitted by activation of peptidergic nerves 
via TRPA1, release of SOM and its effect on sst4 receptors, those of DMTS partially rely 
on SOM release triggered by other routes. SOM is responsible for the inhibition of paw 
swelling by DMTS, but TRPA1 does not contribute to its release. Modulation of MPO 
activity by DMTS is independent of TRPA1 and sst4.
Keywords: transient receptor potential ankyrin 1, sst4, somatostatin, dimethyl trisulfide, polysulfide, carrageenan, 
luminol, ir-676
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inTrODUcTiOn
Inorganic polysulfides (POLYs; hydrogen polysulfide) have been 
demonstrated to be synthesized in the human body (1). These 
species possess antioxidant and radical scavenging properties. 
Beside in vitro systems, these findings were confirmed in lung tis-
sue from patients suffering from chronic obstructive pulmonary 
disease too (2–5). According to some opinions inorganic POLYs 
might mediate persulfidation of cysteine residues of proteins, a 
process traditionally attributed to hydrogen sulfide (H2S) (6). 
Dimethyl trisulfide (DMTS) is an organic trisulfide compound 
naturally occurring in garlic. It is used widely as a food additive 
(7). Recently, DMTS has been patented in the US as a parenteral 
antidote of cyanide poisoning (8). This adds vastly to the transla-
tion potential of the drug. We have reported lately antinociceptive 
properties of DMTS against mechanical hyperalgesia evoked by 
heat injury in mice. Transient receptor potential ankyrin 1 (TRPA1) 
ion channels and somatostatin (SOM) sst4 receptors contribute 
pivotally to these effects (9). Chemically, alkyl trisulfides (such as 
DMTS) produce tri/disulfide metabolites with the thiol groups of 
cysteine amino acids (unlike inorganic POLYs leading to protein 
persulfidation). Others propose organic trisulfides to be sources 
of hydrogen sulfide (H2S) (10). Based on the latest findings, H2S 
in concert with nitric oxide reacts with thiol residues of proteins 
(11, 12). H2S released from organic trisulfides might influence 
protein-associated metal atoms too (13). Organic trisulfides 
were reported to exert antioxidant and anti-inflammatory effects 
mostly studied in animal models of inflammatory bowel disease 
(14–16). Inorganic POLYs are known to interact with functional 
cysteines of the TRPA1 ion channel (17). As mentioned above our 
previous work suggests that one of the targets of DMTS is the ion 
channel TRPA1 as well (9).
Transient receptor potential ankyrin 1 is a non-selective 
cation channel permeable to Ca2+ and Na+. TRPA1 is a member 
of transient receptor potential ankyrin subfamily of ion chan-
nels, itself being a subdivision of the transient receptor potential 
family. TRPA1 is the only ankyrin-type TRP channel to be found 
in mammals. Polymodal TRPA1 channels might be opened by 
chemical substances, temperature, mechanical stimuli, potential 
difference, or changes of pH. Electrophilic agents—most prob-
ably including organic trisulfide compounds—excite TRPA1 
by forming covalent bonds with cysteine residues (18). TRPA1 
is mostly expressed in primary nociceptor neurons, but it was 
evinced in the cornea, skin, pancreas, spleen, lung, kidney, 
testis, and the human endometrium (19). Expression of TRPA1 
channels in polymorphonuclear granulocytes of patients suffer-
ing from chronic inflammatory disease was shown to correlate 
with nociception (20). The role of TRPA1 is known in complete 
Freund’s adjuvant-induced inflammation. However, no involve-
ment was detected in carrageenan-evoked paw inflammation 
(21, 22). TRPA1 channels are typically expressed by sensory 
neurons containing neuropeptides (e.g., SOM). Activation of the 
channel leads to Ca2+ influx into the nerve endings and release of 
peptides. Earlier we found SOM liberation from murine sensory 
neurons upon stimulation with DMTS (9).
Somatostatin is a cyclic peptide with important endocrine 
function besides its presence in the sensory nervous system 
(23). SOM is expressed in 17.8% of human dorsal root ganglion 
neurons. The peptide might be liberated by TRPA1 agonists 
(24). Unlike most neuropeptides, SOM is distributed by the 
bloodstream and exerts antinociceptive and anti-inflammatory 
effects distant from the release site in numerous animal models of 
inflammatory disease (25). These could be ameliorated by deple-
tion of peptides from sensory nerves, administration of anti-SOM 
antibody or SOM receptor antagonist (24). According to previous 
data, these effects are mediated by one of five SOM receptors: 
sst4 (9, 26–29). Antinociceptive and anti-inflammatory effects 
could be mimicked by two different agonists (TT-232, J-2156) 
of sst4 receptors. The agonists were ineffective in animals lacking 
the corresponding functional receptor (24, 30). Sst4 is present 
in sensory neurons, lymphocytes, and vascular endothelial cells 
enabling the transmission of the aforementioned beneficial effects 
of SOM (25).
In the present study, we set out to investigate the effect of inor-
ganic sodium POLY and DMTS on the sensory-SOM-sst4 system 
in carrageenan-induced hind paw inflammation in genetically 
engineered mice lacking either functional TRPA1 or sst4. Both 
mechanical nociception and inflammatory parameters, such as 
paw swelling and myeloperoxidase (MPO) activity of accumu-
lated neutrophil granulocytes, were assessed.
MaTerials anD MeThODs
animals
Experiments were conducted on genetically modified male 
mice lacking functional TRPA1 or sst4 receptors (KO) and their 
wild-type counterparts (WT; 2–4  months, 20–25  g) (27, 31). 
Age-matched animals were used in the study. The original 
heterozygous TRPA1 breeding pair was a generous gift from 
Pierangelo Geppetti (University of Florence, Italy). These mice 
were originally generated and characterized by Bautista and 
colleagues (31). Neither the strain with genetic modification of 
TRPA1 nor that with modified sst4 gene is available commer-
cially. TRPA1 and sst4 WT and KO breeding lines were produced 
by crossing respective heterozygote animals. WT and KO animals 
were chosen from the resulting litter and used for further breeding 
(i.e., WT mice were mated with WT ones and KO mice with KO 
ones). For the fifth-generation clean WT and KO breeding lines 
were established and maintained by inbreeding. All animals were 
genotyped until generation 5 and random sentinel litters of the 
WT and KO lines afterward. Due to poor breeding performance 
of the sst4 colony, heterozygotes were used in the breeding even 
after the fifth generation and all offspring were genotyped for 
an extended period of time. Animals were bred and kept in the 
Laboratory Animal Centre of University of Pécs under standard 
pathogen free conditions at 24–25°C, 12 h light/dark cycles. Mice 
were housed in groups of 5–10 in polycarbonate cages (330 cm2 
floor space, 12 cm height) on wood shavings bedding. Animals 
were provided standard diet and water ad  libitum. All experi-
mental procedures were carried out according to the European 
Communities Council Directive of 2010/63/EU. The studies 
were approved by the Ethics Committee on Animal Research, 
University of Pécs (license number: BA02/2000-47/2017).
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carrageenan-induced hind Paw 
inflammation
Inflammation of one hind paw was triggered by intraplantar 
injection of carrageenan (20 µL, 3% in saline). The contralateral 
paw received saline. The side of carrageenan injection was ran-
domized. Animals were treated with either POLY (17 µmol/kg, 
i.p.) or DMTS (250 µmol/kg, i.p.) or the respective vehicle 30 min 
before challenge of the paws and every 60 min afterward (seven 
times altogether). POLY was prepared freshly before each app-
lication. DMTS was prepared daily.
Preparation of POlY and DMTs solutions
Polysulfide was prepared as described earlier (32). Stock solu-
tions of hypochlorous acid and sodium sulfide nonahydrate 
were prepared in distilled water using polypropylene tubes 
blown with nitrogen gas beforehand. All later dilutions and 
reactions were performed in similar tubes. Reagents were kept 
on ice. Concentration of hypochlorous acid was calculated 
from the light extinction of the solution at 292 nm wavelength 
(E292 = 350 M−1cm−1). Concentration of sulfide was derived from 
the extinction at 230 nm (E230 = 7700 M−1cm−1) and the reaction 
with 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB). Extinction of 
the reaction product of sulfide and DTNB was measured at 412 nm 
(E412 = 28,200 M−1cm−1). Sulfide concentration was calculated as 
the mean of the two values yielded by direct spectrophotometry 
and reaction with DTNB. Stock solutions of hypochlorous acid 
and sulfide were prepared daily. Sulfide stock solution was diluted 
further in distilled water to 60 mM. Hypochlorous acid solution 
was added slowly under stirring to produce 20 mM in the final 
volume. The reaction of sulfide and hypochlorous acid produces 
POLY. This POLY solution was diluted to twofold in distilled 
water containing 4.17% v/v 10x concentrated phosphate-buffered 
saline (PBS, pH 7.4). This amount of PBS renders the POLY solu-
tion isosmotic. Concentrated hydrochloric acid was then added 
by 5  µL under stirring to set the pH to 7.4 (app. 25–30  µL, as 
required). Concentration of the resulting POLY solution was 
measured by cold cyanolysis, as described earlier (33). Shortly, 
the isosmotic and isohydric POLY solution was alkalized by the 
addition of NH4OH and reacted with KCN. After 25 min incuba-
tion at room temperature formaldehyde and Goldstein reagent 
(FeCl3 dissolved in 18.38% HNO3) were added. Absorbance of 
the formed orange product was detected after 15 min reaction 
time at room temperature at 460 nm. POLY concentration was 
calculated using a standard curve constructed with KSCN. The 
buffered solution was found to contain 3.3 mM POLY, yielding 
a dose of 17 µmol/kg at 5 mL/kg. Isosmotic and isohydric POLY 
solution was injected into the mice immediately after production. 
PBS was used as vehicle control.
A DMTS solution of 1 M was prepared in dimethyl sulfoxide 
(DMSO). This solution was diluted to 100  mM in saline con-
taining 2% v/v polysorbate 80. After slow dissolution, a further 
dilution commenced in saline to 25 mM. The 25 mM solution 
was injected at 10 mL/kg i.p. resulting in a dose of 250 µmol/kg. 
In vehicle, DMSO was applied instead of 1 M DMTS solution. 
Final DMTS solutions contained 2.24% v/v DMSO and 0.45% v/v 
polysorbate 80. Vehicle had 2.5% v/v DMSO.
Measurement of Mechanical Pain 
Threshold of the hind Paws
Mechanical hyperalgesia evoked by carrageenan was assessed by 
dynamic plantar aesthesiometry (DPA, Hugo Basile, Italy) 2, 4, 
and 6 h after the initiation of inflammation. Baseline values were 
taken on three separate days before paw challenge. Stimulator of 
the instrument reached 10 g “force” in 4 s.
Detection of Paw swelling  
by Plethysmometry
Swelling of inflamed and control hind paws was measured by 
plethysmometry (Hugo Basile, Italy). These measurements were 
performed following DPA experiments to prevent stressing the 
animals before aesthesiometry. Control measurements were con-
ducted right after control DPA experiments on three separate days 
preceding paw challenge. Paw volumes were measured in cm3.
Detection of MPO activity in the hind 
Paws by luminescent imaging
Animals were anesthetized with ketamine and xylazine (120 and 
12 mg/kg) 6 h after hind paw challenge. Mice were injected i.p. with 
sodium luminol (5-amino-2,3-dihydro-1,4-phthalazine-dione; 
150  mg/kg) dissolved in sterile PBS. Luminol signals reactive 
oxygen species correlated with MPO activity of neutrophil 
granulocytes via luminescence (34). Bioluminescence of luminol 
was captured 10 min after administration. Measurements were 
conducted in an IVIS Lumina II (PerkinElmer, Waltham, USA; 
120  s acquisition, F/stop  =  1, Binning  =  8) instrument and 
Living Image® software (Perkin-Elmer, Waltham, USA). Identical 
regions of interest (ROIs) were applied to both hind paws and 
calibrated units of luminescence (total radiance =  total photon 
flux/s) originating from the ROIs were detected (35).
chemicals
All chemicals were purchased from Sigma Aldrich, Hungary 
unless otherwise stated. DMSO was from Reanal, Hungary. 
Ketamine was from Richter Gedeon, Hungary. Xylazine was from 
Eurovet Animal Health BV, Netherlands.
statistics
Data are presented as mean ± SEM. Two-way repeated-measure 
ANOVA followed by Bonferroni’s test was used for mecha-
nonociceptive threshold and paw volume data. Some data on 
mechanonociceptive threshold were analyzed by plain one-way 
ANOVA followed by Tukey’s test. Results on MPO activity 
were analyzed by plain one-way ANOVA and Bonferroni’s test. 
Statistical analysis was performed by GraphPad Prism 5 software.
resUlTs
inhibition of carrageenan-evoked 
Mechanical Pain by POlY is TrPa1  
and sst4 receptor-Dependent
Carrageenan-injected paws of TRPA1 WT and KO mice under-
going vehicle administration developed significantly lowered 
mechanical pain threshold compared to saline-treated ones 
FigUre 1 | Antinociceptive effect of sodium polysulfide (POLY, 17 µmol/kg) in carrageenan-induced paw inflammation is mediated by transient receptor potential 
ankyrin 1 (TRPA1) and sst4 receptors. Mechanical pain threshold of saline or carrageenan-injected (3% in 20 µL saline) hind paws of (a) TRPA1 WT, (B) TRPA1 KO, (c) 
sst4 receptor WT, and (D) sst4 receptor KO animals in response to POLY or vehicle treatment. Data are shown as mean ± SEM. n = 6–8. cp < 0.05 vs. saline-injected 
paws. pp < 0.05 vs. vehicle of POLY. gp < 0.05 vs. TRPA1 WT animals. Two-way repeated-measure ANOVA followed by Bonferroni’s multiple comparison test.
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(n = 6–7; Figures 1A,B). POLY significantly reduced mechanical 
hyperalgesia in carrageenan-injected feet of TRPA1 WT animals 
in comparison with those of vehicle-treated ones (4.89 ± 0.36 vs. 
6.22 ± 0.81 g at 4 h after challenge; n = 6–7; Figure 1A). Inhibitory 
effect of POLY on mechanical nociception in carrageenan-treated 
hind paws was lacking in TRPA1 KO animals compared to WT ones 
(7.12 ± 0.6 vs. 5.16 ± 0.44 g, 6.22 ± 0.81 vs. 4.64 ± 0.4 g, 5.97 ± 0.37 
vs. 4.46 vs. 0.26 g at 2, 4 and 6 h after challenge; n = 6–7; Figure 1B). 
POLY had no effect on the mechanical pain thresholds of saline-
injected feet of TRPA1 WT and KO animals (Figures 1A,B).
Similar to the above, both sst4 receptor WT and KO animals 
treated with the vehicle of POLY responded with reduced 
mechanical pain threshold to carrageenan administration 
(n = 6–8; Figures 1C,D). POLY significantly relieved mechani-
cal nociception 6 h after challenge in carrageenan-injected feet 
of sst4 WT animals compared to those of vehicle-treated ones 
(3.85 ±  0.27 vs. 5.35 ±  0.45  g at 6  h after challenge; n =  7–8; 
Figure 1C). No effect of POLY was observed in sst4 KO mice. 
POLY did not affect mechanical pain thresholds of saline-treated 
paws of sst4 receptor WT and KO animals (Figures 1C,D).
no exclusive role of TrPa1 ion   
channel in the Protective effect  
of DMTs in carrageenan-induced 
Mechanical hyperalgesia
Carrageenan-injected hind paws of TRPA1 WT and KO 
animals treated with vehicle of DMTS developed mechanical 
hyperalgesia compared to saline-injected contralateral paws 
(n =  6–7; Figures  2A,B). Carrageenan-treated hind paws of 
TRPA1 WT mice undergoing DMTS administration showed 
significantly less hyperalgesia than those administered 
vehicle (n = 6–7; Figure 2A). Protective effect of DMTS was 
reduced in carrageenan-injected feet of TRPA1 KO animals 
compared to those of TRPA1 WT ones (n = 6–7; Figure 2B). 
However, DMTS still alleviated mechanical hyperalgesia in 
carrageenan-treated feet of TRPA1 KO mice at 2 and 4 h after 
challenge in comparison with vehicle-treated animals (n = 7; 
Figure 2B). Saline-injected paws of DMTS and vehicle-treated 
TRPA1 WT and KO animals did not differ from one another 
(Figures 2A,B).
Carrageenan-injected hind paws of sst4 receptor WT and 
KO animals being administered vehicle of DMTS exhibited 
mechanical hyperalgesia compared to saline-injected control 
feet (n = 7–8; Figures 2C,D). Carrageenan-treated hind paws 
of sst4 receptor WT mice injected with DMTS developed 
significantly smaller hyperalgesia than those of vehicle-treated 
control animals (n = 7; Figure 2C). Mechanical pain threshold 
of saline-treated paws of DMTS and vehicle-injected sst4 recep-
tor WT animals did not differ statistically (Figure 1C). DMTS 
did not inhibit nociception in carrageenan-treated feet of sst4 
receptor KO animals compared to those of their WT counter-
parts (Figure  2D). Saline-treated feet of vehicle-injected sst4 
receptor KO animals developed significantly larger mechanical 
pain threshold at 6 h than those of DMTS-treated ones (n = 7–8; 
Figure 1D).
FigUre 2 | Antinociceptive effect of dimethyl trisulfide (DMTS, 250 µmol/kg) in carrageenan-evoked paw inflammation is independent of the transient receptor 
potential ankyrin 1 (TRPA1) ion channel, but is mediated by somatostatin (SOM) sst4 receptors. Effect of DMTS or vehicle treatment on mechanical pain threshold of 
either saline or carrageenan-treated (3% in 20 µL saline) hind paws of (a) TRPA1 WT, (B) TRPA1 KO, (c) sst4 receptor WT, and (D) sst4 receptor KO mice. Data are 
shown as mean ± SEM. n = 6–8. cp < 0.05 vs. saline-injected paws. dp < 0.05 vs. vehicle of DMTS. gp < 0.05 vs. TRPA1 WT animals. Two-way repeated-measure 
ANOVA followed by Bonferroni’s multiple comparison test.
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POlY Does not affect Paw swelling 
evoked by carrageenan
Both vehicle and POLY-treated TRPA1 WT and KO mice 
exhibited significant paw swelling upon carrageenan stimula-
tion of the hind paws. POLY had no statistically significant 
inhibitory effect on the swelling of the feet in TRPA1 WT 
or KO animals. T-values of two-way ANOVA followed by 
Bonferroni’s test for the comparison of POLY- and vehicle-
treated carrageenan-injected paws of TRPA1 KO animals 
are the following: 0  h, 0.04846; 2  h, 0.8061; 4  h, 1.573; and 
6  h, 1.018. A trend for inhibition by POLY can be seen in 
carrageenan-injected feet of TRPA1 KO mice in comparison 
to those of vehicle-treated ones that does not reach the level of 
statistical significance (n = 6–7; Figures 3A,B). POLY or vehi-
cle treatment did not change paw volumes of saline-injected 
control paws. Similar results were obtained in sst4 receptor 
WT and KO mice regarding lack of statistically significant 
effect of POLY in either saline or carrageenan-injected paws 
compared to vehicle (n  =  6–8). Volume of carrageenan-
injected hind feet of sst4 KO mice was significantly smaller 
at 4 and 6  h post challenge than those of WT ones (n =  8; 
Figures 3C,D).
Protective effect of DMTs in  
carrageenan-evoked Paw swelling  
is independent of TrPa1, but is  
Mediated Through sst4 receptors
Transient receptor potential ankyrin 1 WT and KO mice devel-
oped significant swelling of the hind feet irrespectively of DMTS 
or vehicle treatment (n =  6–7). DMTS ameliorated swelling at 
6 h in carrageenan-injected feet of TRPA1 WT mice compared 
to those of vehicle-treated ones (n =  6–7; Figure  4A). DMTS 
significantly relieved swelling in carrageenan-treated paws of 
TRPA1 KO mice at 4 and 6 h after challenge in comparison with 
those of vehicle-treated ones (n = 7; Figure 4B). DMTS produced 
a stronger inhibition of swelling in the carrageenan-injected feet of 
TRPA1 KO animals at 4 h than in those of TRPA1 WT mice (n = 7; 
Figure  4B). Edema formation in saline-injected feet of TRPA1 
WT and KO mice was not affected by DMTS or vehicle treatment.
Carrageenan challenge lead to significant paw swelling in sst4 
receptor WT and KO mice irrespectively of vehicle or DMTS treat-
ment (n = 7–8). DMTS relieved edema formation in carrageenan-
treated paws of sst4 WT animals at 6 h in comparison with those 
of vehicle-treated ones (n = 7; Figure 4C). DMTS did not show 
any protective effect in sst4 receptor KO mice (Figure 4D).
FigUre 4 | Alleviating effect of dimethyl trisulfide (DMTS, 250 µmol/kg, i.p.) on edema formation in carrageenan-induced hind paw inflammation is independent  
of the transient receptor potential ankyrin 1 (TRPA1) ion channel, but is mediated by somatostatin (SOM) sst4 receptors. Effect of DMTS or vehicle treatment on  
hind paw edema detected by plethysmometry in saline or carrageenan-treated (3% in 20 µL saline) feet of (a) TRPA1 WT, (B) TRPA1 KO, (c) sst4 receptor WT, and 
(D) sst4 receptor KO mice. Data are shown as mean ± SEM. n = 6–8. cp < 0.05 vs. saline-injected paws. dp < 0.05 vs. vehicle of DMTS. gp < 0.05 vs. TRPA1 WT 
animals. Two-way repeated-measure ANOVA followed by Bonferroni’s multiple comparison test.
FigUre 3 | Sodium polysulfide (POLY; 17 µmol/kg, i.p.) does not affect paw swelling detected by plethysmometry in carrageenan-induced hind paw inflammation. 
Effect of POLY or vehicle treatment on paw swelling of either saline or carrageenan-treated (3% in 20 µL saline) hind paws of (a) transient receptor potential ankyrin 
1 (TRPA1) WT, (B) TRPA1 KO, (c) sst4 receptor WT, and (D) sst4 receptor KO mice. Data are shown as mean ± SEM. n = 6–8. cp < 0.05 vs. saline-injected paws. 
Two-way repeated-measure ANOVA followed by Bonferroni’s multiple comparison test.
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FigUre 5 | Polysulfide (POLY) treatment (17 µmol/kg, i.p.) does not alter myeloperoxidase (MPO) activity shown by luminol bioluminescence in murine hind paws 
with carrageenan-induced inflammation. (a) Bioluminescence in saline and carrageenan-injected (3% in 20 µL saline) hind feet of transient receptor potential ankyrin 
1 (TRPA1) WT and KO animals. (B) Representative bioluminescent images of saline and carrageenan-treated (3% in 20 µL saline) hind paws of TRPA1 WT and  
KO mice illustrating MPO activity. (c) Luminol bioluminescence in saline and carrageenan-treated (3% in 20 µL saline) hind feet of sst4 receptor WT and KO mice. 
(D) Representative bioluminescent images of saline and carrageenan-treated (3% in 20 µL saline) hind paws of sst4 WT and KO animals. Data are shown as 
mean ± SEM. n = 7–8. cp < 0.05 vs. saline-injected paws. One-way ANOVA followed by Bonferroni’s multiple comparison test.
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carrageenan-evoked MPO activity  
of accumulated neutrophil cells is 
Unaffected by administration of POlY
Both TRPA1 WT and KO animals developed significantly ele vated 
MPO activity in carrageenan-injected hind paws independently 
from vehicle or POLY administration (n =  7). POLY did not 
ameliorate MPO activity in any animal groups nor did it affect 
the values of saline-injected control paws (Figures 5A,B). Similar 
data were produced in sst4 receptor WT and KO mice (n = 7–8; 
Figures 5C,D). Fluorescent determination of plasma extravasa-
tion following measurement of MPO activity produced no sig-
nificant difference in either POLY or DMTS treated groups of any 
genetic background. (Datasheet 1 in Supplementary Material).
DMTs inhibits MPO activity of 
accumulated neutrophil granulocytes 
independently of sst4 receptors
Carrageenan-injected feet of TRPA1 WT and KO animals 
developed significantly increased MPO activity irrespectively 
of vehicle or DMTS administration (n = 6–7). MPO activity in 
carrageenan-injected hind paws of DMTS-treated TRPA1 WT 
and KO mice tends to be smaller than in those of vehicle-treated 
ones (Figures 6A,B). Sst4 WT and KO mice showed significantly 
elevated MPO activity upon carrageenan injection independently 
of vehicle or DMTS treatment (n =  7–9). DMTS did not alter 
MPO activity of saline-injected control paws. DMTS ameliorated 
MPO activity in carrageenan-treated feet of both sst4 WT and 
KO mice compared to those of vehicle-treated ones (n =  7–9; 
Figures 6C,D).
DiscUssiOn
The main novel findings of the current study are the following:
 i. Antinociceptive effect of POLY in carrageenan-evoked paw 
inflammation depends on TRPA1 ion channel opening by the 
drug, release of SOM from the activated peptidergic sensory 
nerve fibers and subsequent activation of sst4 receptors, as 
the antihyperalgesic effect of POLY was absent in TRPA1 and 
sst4 KO mice.
 ii. Organic trisulfide DMTS possessed an antinociceptive effect 
not only in TRPA1 and sst4 receptor WT animals, but also in 
TRPA1 KO ones. Protective activity was significantly weaker 
in TRPA1 KO mice than in WT ones. These findings imply tar-
get molecules of DMTS on sensory nerve endings other than 
TRPA1 leading to activation of the fibers and SOM release.
FigUre 6 | Dimethyl trisulfide (DMTS) administration (250 µmol/kg, i.p.) decreases myeloperoxidase (MPO) activity indicated by luminol bioluminescence in sst4 
receptor WT and KO mice undergoing carrageenan-induced inflammation of the hind foot. (a) Bioluminescence in saline and carrageenan-treated (3% in 20 µL 
saline) hind paws of transient receptor potential ankyrin 1 (TRPA1) WT and KO animals. (B) Representative bioluminescent images of saline and carrageenan-treated 
(3% in 20 µL saline) hind paws of TRPA1 WT and KO mice depicting MPO activity. (c) Luminol bioluminescence in saline and carrageenan-treated (3% in 20 µL 
saline) hind paws of sst4 receptor WT and KO mice. (D) Representative bioluminescent images of saline and carrageenan-injected (3% in 20 µL saline) hind paws  
of sst4 WT and KO animals. Data are shown as mean ± SEM. n = 6–9. cp < 0.05 vs. saline-injected paws. dp < 0.05 vs. carrageenan-injected paws of mice  
treated with the vehicle of DMTS. One-way ANOVA followed by Bonferroni’s multiple comparison test.
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 iii. Polysulfide administration exhibited no statistically sig-
nificant effect on carrageenan-induced paw edema, unlike 
DMTS that ameliorated swelling in TRPA1 WT, KO, and 
sst4 receptor WT mice. These data point toward other 
mediators of DMTS effect than TRPA1 on peptidergic 
nociceptors.
 iv. Polysulfide had no effect on MPO activity of the inflamed 
hind paws. Interestingly, DMTS significantly lowered MPO 
activity characterizing neutrophil accumulation in sst4 recep-
tor WT and KO animals. A similar trend emerged in TRPA1 
WT and KO animals not bestriding the limit of statistical 
significance. Our results indicate a mechanism of action of 
DMTS regarding MPO activity differing completely from the 
one suggested by data on mechanical nociception and paw 
swelling. Activation of TRPA1, release of SOM and its effect 
on sst4 receptors do not contribute to the inhibition of MPO 
activity by DMTS.
Most authors familiar with the area agree that activation of 
TRPA1 ion channels on nociceptor sensory nerve endings by H2S, 
POLYs, or other agonists is painful due to activation of the ascend-
ing pain pathway (17, 36, 37). We do not debate that TRPA1 recep-
tor activation is acutely painful. Intraperitoneal administration 
of POLY and DMTS surely evoked abdominal discomfort in our 
experimental animals. However, it is not only well documented 
scientifically, but exploited clinically that activation of peptidergic 
primary sensory neurons mediates a later onset antinociceptive 
effect (we refer to the dermal patch Qutenza® with high capsaicin 
content used in the therapy of neuropathic pain and relying on a 
different mechanism of action than that suggested for POLY and 
DMTS by the present work).
It was reported earlier that peptidergic sensory nerve endings 
release neuropeptides upon activation, among them SOM. Beside 
a population of nociceptors SOM is expressed in the central 
nervous system and peripheral tissues, too (23, 38). Treatment 
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with TRPA1 receptor agonists or nociceptor activation by other 
means leads to SOM release from primary sensory neurons and 
the peptide reaches significant concentration in the bloodstream 
(9, 39–42). SOM exerts antinociceptive and anti-inflammatory 
effects at parts of the body distant from the site of release. These 
effects were shown to be mediated by somatostatin sst4 receptors 
(9, 25, 28, 40). Antinociceptive and anti-inflammatory SOM effects 
are obviated by somatostatin receptor antagonist, depletion of 
SOM from sensory nerves, an antibody catching the peptide and 
genetic lack of the sst4 receptor. On the other hand, sst4 receptor 
agonists induce similar beneficial effects to those of SOM (24, 
30). Sst4 receptors expressed in sensory neurons, lymphocytes, 
and vascular endothelial cells might contribute to the protective 
effect (25). Non-neuronal sources of TRPA1 activation-induced 
surge of SOM in the circulation shall not be taken into account, 
hence denervation or defunctionalization of the area exposed to 
TRPA1 agonist prevented such effects (39, 43).
Somatostatin is a prerequisite of antihyperalgesic and anti-
inflammatory effects mediated by peptidergic nerve endings. 
It is known that other mediators contribute too. The sensory 
neuron-dependent antinociceptive effect was abolished by 
antagonism of opioid receptors. Opioid peptides might be 
released from sensory neurons and leukocytes (39).
According to our data activation routes of the sensory neuron– 
somatostatin axis other than TRPA1 ion channels are in play in 
case of DMTS, as the organic trisulfide elicited antinociceptive 
effect and inhibited paw swelling independently of TRPA1, but 
still via sst4 receptors. Similar mechanisms might have been 
in play leading to the trend of inhibition of hind paw edema 
detected by plethysmometry in TRPA1 KO mice treated with 
POLY (Figure 3B). Several such mechanisms were suggested for 
H2S. TRPV1 channels co-expressed with TRPA1 can be ruled 
out because DMTS failed to produce Ca2+ signals in CHO cells 
expressing the channel (9). Taken into account that organic tri-
sulfides are donors of H2S, these mechanisms might be valid for 
DMTS as well (10). Conversion of inorganic POLY into sulfide 
in living cells is an active field of research and remains to be 
elucidated. H2S was reported to activate T-type CaV 3.2 channels 
of sensory neurons (36). These ion channels modulate pain sensa-
tion by regulating the activity of sensory neurons (44). It has to 
be noted that inhibition of CaV 3.2 channels by H2S was detected, 
too. Supraphysiological concentration of H2S behaves rather as 
an activator, while normal concentration leads to inhibition of 
T-type Ca2+ channels (45). Voltage-gated K+ channels are poten-
tial mediators of the effects of DMTS too. KV 4.3 voltage-gated K+ 
channels are expressed in DRG neurons (46). H2S was reported 
to contract murine gastric smooth muscle by persulfidation of 
KV 4.3 channels. Inhibition of KV 4.3 channels was reproducible 
in H293 cells and could be diminished by a reducing agent and 
a blocker of free thiol groups that prevent protein persulfidation 
(47). Ability of the organic trisulfide DMTS to inhibit voltage-
gated K+ channels could contribute to depolarization of peptider-
gic sensory neurons and SOM release from these cells.
Sodium POLY is an anionic compound, thus it most probably 
cannot penetrate into the central nervous system. It reacts read-
ily with cysteine amino acids of proteins and loses its negative 
charge. However, proteins are excluded from the brain and cannot 
transport POLY there. This way the effects of POLY described in 
the present study might rely on a peripheral mechanism (even 
SOM released from the sensory nerves is excluded from the cen-
tral nervous system). Potassium POLY was found to enter intact 
HEK293T cells and produce protein persulfidation (6). Organic 
trisulfides such as DMTS are highly lipophilic and penetrate the 
blood–brain barrier freely. An uptake via facilitated diffusion or 
active transport has been proposed in case of DMTS too (48). 
Target proteins in the spinal cord and brain available for DMTS 
might contribute to its differing effect on nociception from that 
of POLY.
Mechanical pain threshold data of carrageenan-injected feet 
of TRPA1 and sst4 WT and KO animals treated with vehicle of 
POLY or DMTS were analyzed by one-way ANOVA followed by 
Tukey’s test. Statistically significant difference was found between 
POLY- and DMTS-treated TRPA1 WT mice at 2 h (p <  0.05), 
POLY- and DMTS-treated sst4 WT animals at 0 (p < 0.05) and 6 h 
(p < 0.01), POLY- and DMTS-treated sst4 KO mice at 0 (p < 0.05) 
and 6 h (p < 0.01). It is needless to state that it makes no sense 
to compare TRPA1 and sst4 strains. The above differences do not 
influence the power of conclusions on the mechanism of either 
DMTS or POLY action because conclusions were drawn from 
within either POLY- or DMTS-treated groups, where influencing 
factors were homogeneous.
Interestingly, a smaller paw volume was detected at 4 and 6 h 
in the carrageenan-injected hind paws of POLY-treated sst4 KO 
mice compared to the WT ones. This might conflict with pro-
tective nature of SOM discussed above. Compensatory changes 
in the expression of inflammatory genes in knockout animals 
might be responsible. Unfortunately, the sst4 receptor gene-
modified mouse strain utilized in the present study has not been 
characterized yet in that regard. However, similar results were 
published on another protective neuropeptide and its receptor: 
pituitary adenylate cyclase-activating polypeptide (PACAP) and 
VPAC1 receptor. PACAP is usually known as a protective peptide. 
Experimental autoimmune encephalomyelitis (EAE) was found to 
be more severe in PACAP peptide knockout mice (49). Mirroring 
our findings on sst4 SOM receptors, animals genetically lacking 
VPAC1 PACAP receptors exhibited ameliorated responses in the 
same EAE model and in dextran sulfate-evoked colonic inflam-
mation too (50, 51). VPAC1 KO mice had decreased mRNA levels 
of Th2 cytokines and chemokines (50). A similar compensatory 
mechanism in sst4 KO animals might influence the activation of 
neutrophils and macrophages—the dominant cells invol ved in 
carrageenan-induced paw edema inflammation—and decrease 
edema formation (52).
An inhibitory effect of DMTS on MPO activity was found that 
is mediated by neither TRPA1 nor SOM. Sulfide potentially being 
released from DMTS directly inhibits MPO activity of neutrophil 
granulocytes offering a straightforward mechanism (10, 53). 
Sulfide was documented to inhibit neutrophil cell accumulation 
and formation of reactive oxygen species in murine ventilator-
induced lung injury, as well as to interfere with Ca2+-dependent 
cytoskeletal activities (chemotaxis and release of azurophilic 
granules) of human neutrophils (54, 55). H2S suppressed adher-
ence of rat neutrophil granulocytes in the mesenteric blood 
vessels detected by intravital microscopy. The effect was found 
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to be mediated by the inhibition of KATP ion channels (56, 57). 
Similarly, recruitment of human neutrophil cells was reduced by 
sulfide by the stimulation of L-selectin shedding. L-selectin is 
necessary for the adhesion of the inflammatory cells to endothe-
lium. Activation of TNF-α-converting enzyme (ADAM-17) is 
supposed to be responsible (58).
We conclude that activation of peptidergic sensory neurons, 
release of SOM and subsequent activation of sst4 receptors are 
important mediators of antihyperalgesic effect of both POLY 
and DMTS. Unlike POLY, DMTS possesses anti-inflammatory 
activity too. The aforementioned mechanism contributes to the 
amelioration of edema formation by DMTS complemented by 
other means of peptidergic-nerve activation as the effect depends 
on the presence of functional sst4 receptors. DMTS is able to 
suppress MPO activity of neutrophil granulocytes at the site of 
inflammation without the involvement of the sensory neuron–
SOM axis. Superior chemical stability, favorable pharmacokinetic 
properties, and significant translational potential—due to being 
a recognized food additive and having been patented as cyanide 
antidote—set DMTS in front of sodium POLY as a candidate of 
drug development which is only set back by the characteristic 
odor of the substance.
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